399 results on '"Zambon, Carlo-Federico"'
Search Results
152. Un peptide diabetogeno carcinoma pancreatico-associato induce la sintesi di ossido nitrico negli epatociti di ratto
153. Gene therapy with HSV-TK: a promising tool for pancreatic cancer treatment?
154. Significato clinico della stadiazione molecolare (CEA mRNA su cellule circolanti) del carcinoma del colon retto
155. Determinazione quantitativa del PSA mRNA su sangue periferico con metodica TaqMan: limiti analitico-clinici
156. Diabete associato a carcinoma pancreatico: ruolo di un fattore di 2026 D
157. Mutazioni puntiformi di K-ras nel carcinoma pancreatico: studio del DNA estratto da siero e bile
158. Il fenotipo metastatico del carcinoma del colon retto stimola la produzione di collagene da parte dei fibroblasti
159. Ruolo diagnostico degli anticorpi antitransglutaminasi, antigliadina e antiendomisio nella malattia celiaca
160. Standardization of K-ras point mutations detection in serum derived DNA: use of the restriction enzyme BstO I
161. Serum antibodies anti-H. pylori and anti CagA: a comparison between four different assays
162. Clinical utility of total (tPSA) and free PSA (fPSA) and of circulating PSA and PSM mRNA determination in diagnosing prostate cancer (PC)
163. Pancreatic cancer associated diebetogenic factor:a low molecular weight peptide possibly involved
164. Inflammatory bowel diseases: from pathogenesis to laboratory testing
165. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1
166. Limiti analitico-clinici della determinazione del PSA e PSM mRNA circolanti nella diagnosi di carcinoma prostatico
167. MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus
168. Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer
169. Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to acquire an immunesuppressive phenotype by downregulating CTLA4
170. Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study
171. Pancreatic Cancer Alters Human CD4+ T Lymphocyte Function
172. Interleukin 1β and tumor necrosis factor-α polymorphisms in autoimmune gastritis
173. VKORC1,CYP2C9andCYP4F2genetic-based algorithm for warfarin dosing: an Italian retrospective study
174. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N‐terminal peptide (NT‐S100A8)
175. Analogs of Vitamin E Epitomized by α-Tocopheryl Succinate for Pancreatic Cancer Treatment
176. M1587 EPIYA-C Motifs Are Main Determinants of Intestinal Metaplasia and Gastric Mucosa Atrophy
177. Antibodies against Synthetic Deamidated Gliadin Peptides for Celiac Disease Diagnosis and Follow-Up in Children
178. Suicide Gene Therapy With the Yeast Fusion Gene Cytosine Deaminase/Uracil Phosphoribosyltransferase Is Not Enough for Pancreatic Cancer
179. A New Indirect Chemiluminescent Immunoassay to Measure Anti–tissue Transglutaminase Antibodies
180. Gastropanel: A useful screening test in paediatric populations
181. Mitochondrial DNA D-Loop in Pancreatic Cancer
182. Decreased Total Lymphocyte Counts in Pancreatic Cancer: An Index of Adverse Outcome
183. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
184. Retrovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transfer in Pancreatic Cancer Cell Lines: An Incomplete Antitumor Effect
185. A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor
186. Metastatic colo-rectal cancer cells stimulate collagen production by fibroblasts
187. K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA
188. CEA mRNA Identification in Peripheral Blood Is Feasible for Colorectal, But Not for Gastric or Pancreatic Cancer Staging
189. Effect of cagA Status on the Sensitivity of Enzyme Immunoassay in Diagnosing Helicobacter pylori–Infected Children
190. Pancreatic Cancer Alters Human CD4+ T Lymphocyte Function.
191. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8).
192. Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting?
193. Effect of cagA Status on the Sensitivity of Enzyme Immunoassay in DiagnosingHelicobacter pylori–Infected Children.
194. Pancreatic Cancer Alters Human CD4+T Lymphocyte Function
195. Analogs of Vitamin E Epitomized by -Tocopheryl Succinate for Pancreatic Cancer Treatment
196. Suicide Gene Therapy With the Yeast Fusion Gene Cytosine Deaminase/Uracil PhosphoribosyltransferaseIs Not Enough for Pancreatic Cancer
197. M1558 Pancreatic Cancer Biomarkers Discovery By SELDI-TOF-MS
198. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival
199. Challenges of Preimplantation Genetic Counselling in the Context of Cystic Fibrosis and Other CFTR-Related Disorders: A Monocentric Experience in a Cohort of 92 Couples.
200. MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.